Company / Debt per Share
SUTRO BIOPHARMA, INC. Debt per Share History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.35
FY2022
5-year range
$0.35 / $0.55
FY2018-FY2022
Trend
-36.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.06 to $0.35 over the past 2 years.
Based on SEC 10-K filings.
0.35 in FY2022 with a 3-year CAGR of -3.3%.
Improved from $1.06 to $0.35 over the past 2 years.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -3.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, debt per share decreased 36.0% year-over-year.
- Peak debt per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.35 | -36.0% |
| FY2021 | $0.55 | -48.3% |
| FY2020 | $1.06 | +173.5% |
| FY2019 | $0.39 | -98.2% |
| FY2018 | $21.49 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026